AILEEN CASSIDY: Open Payments
NPI 1790989127 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 47 payments from 18 companies in 2025. Trend: 2023 $1,604 · 2024 $1,804 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $202 |
| Incyte Corporation | 6 | $156 |
| Organon LLC | 4 | $104 |
| ABBVIE INC. | 5 | $81 |
| Amgen Inc. | 3 | $77 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| UCB, Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $62 |
| Galderma Laboratories, L.P. | 3 | $61 |
| PFIZER INC. | 2 | $51 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, OTEZLA, VTAMA, Bimzelx, CIBINQO, ILUMYA.
Industry payments across MD — which companies pay providers there.
